Re: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer [1]

Journal of the National Cancer Institute

Volumn 99, Issue 15, 2007, Pages 1210-

  Leo, Francesco ^a   De Pas, Tommaso ^a   Catalano, Gianpiero ^a   Piperno, Gaia ^a   Curigliano, Giuseppe ^a   Solli, Piergiorgio ^a   Veronesi, Giulia ^a   Petrella, Francesco ^a   Spaggiari, Lorenzo ^a,b  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEALTH CARE QUALITY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SURVIVAL RATE; SURVIVAL TIME; THORACOTOMY; ADJUVANT THERAPY; COMPARATIVE STUDY; LUNG RESECTION; LUNG TUMOR; LYMPHADENECTOMY; MEDIASTINUM; METASTASIS; METHODOLOGY; MULTICENTER STUDY; NOTE; PATHOLOGY; STATISTICS; TREATMENT OUTCOME; CANCER MORTALITY; LUNG ADENOCARCINOMA; PROGNOSIS;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MEDIASTINUM; MULTICENTER STUDIES; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SAMPLE SIZE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34547805217     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm051     Document Type: Letter

References (7)

1. van Meerbeeck J, Kramer GWPM, Van Schil PEY, Legrand C, Smit EF, Schramel F, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Institute 2007;99: 442-50.
2. Regnard JF, Perrotin C, Giovannetti R, Schussler O, Petino A, Spaggiari L, et al. Resection for tumors with carinal involvement: Technical aspects, results, and prognostic factors. Ann Thorac Surg 2005;80: 1841-6.
3. Spaggiari L, Leo F, Veronesi G, Solli P, Galetta D, Tatani B, et al. Superior vena cava resection for lung and mediastinal malignancies: A single-center experience with 70 cases. Ann Thorac Surg 2007;83:223-9.
4. Ponn RB, LoCicero J, Daly BDT. Surgical treatment of non-small cell lung cancer. In: Shields TW, LoCicero J, Ponn RB, Rusch VW, editors. General thoracic surgery. 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2005. p. 1570.
5. Lardinois D, De Leyn P, Van Schil P, Porta RR, Waller D, Passlick B, et al. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. Eur J Cardiothorac Surg 2006;30:787-92.
6. Sugarbaker DJ, Herndon J, Kohman LJ, Krasna MJ, Green MR. Results of Cancer and Leukemia Group B protocol 8935. A multi-institutional phase II trimodality trial for stage IIIA (N2) non-small-cell lung cancer. J Thorac Cardiovasc Surg 1995;109:473-85.
7. Kramer GW, Legrand CL, Van Schil P, Uitterhoeve L, Smit EF, Schramel F, et al. Quality assurance of thoracic radiotherapy in EORTC 08941: A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy. Eur J Cancer 2006;42:1391-8.